FindTrial
Sign In

Ocular toxicity profile of hydroxychloroquine and its association with blood level of hydroxychloroquine.

Ocular toxicity profile of hydroxychloroquine(HCQ) and its association with blood levels :A hospital based pilot study in north east India - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/076780
Enrollment
110
Registered
2024-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M05-M14- Inflammatory polyarthropathies

Interventions

Intervention1: NIL: NIL

Sponsors

Phulen Sarma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients suffering from autoimmune disease attending General medicine OPD and on HCQ. 2. Patient on stable daily dose of HCQ for at least 6 months 3. Have stable dose of glucocorticoid/immunosuppressant dose during the preceding 4 weeks. 4. Age of 18 to 60 yrs would be included in the study. 5. Both sex Male and Female

Exclusion criteria

Exclusion criteria: 1. Patients with pre-existing retinal diseases 2. Media opacity obscuring retinal evaluation. 3. Patient not cooperative for visual field evaluation. 4. Pregnant and lactating woman. 5. eGFR lover than 60 ml/min, chronic alcoholism and liver failure.

Design outcomes

Primary

MeasureTime frame
To find the ocular toxicity profile of hydroxychloroquine in patients attending Rheumatology clinic on HCQ therapy.Timepoint: Single time point while attending the OPD—

Secondary

MeasureTime frame
To find the association between HCQ blood level & ocular toxicity.Timepoint: Single time point at the time of attending OPD—

Countries

India

Contacts

Public ContactDr Phulen Sarma

Department of Pharmacy Practice

ajeeshmohammed.p@gmail.com9946785452

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026